Data_Sheet_1_Stem Cell-Based Therapy for Experimental Ischemic Stroke: A Preclinical Systematic Review.docx (104.14 kB)
Download file

Data_Sheet_1_Stem Cell-Based Therapy for Experimental Ischemic Stroke: A Preclinical Systematic Review.docx

Download (104.14 kB)
dataset
posted on 14.04.2021, 04:58 by Xi-Le Zhang, Xiao-Guang Zhang, Yan-Ran Huang, Yan-Yan Zheng, Peng-Jie Ying, Xiao-Jie Zhang, Xiao Lu, Yi-Jing Wang, Guo-Qing Zheng

Stem cell transplantation offers promise in the treatment of ischemic stroke. Here we utilized systematic review, meta-analysis, and meta-regression to study the biological effect of stem cell treatments in animal models of ischemic stroke. A total of 98 eligible publications were included by searching PubMed, EMBASE, and Web of Science from inception to August 1, 2020. There are about 141 comparisons, involving 5,200 animals, that examined the effect of stem cell transplantation on neurological function and infarct volume as primary outcome measures in animal models for stroke. Stem cell-based therapy can improve both neurological function (effect size, −3.37; 95% confidence interval, −3.83 to −2.90) and infarct volume (effect size, −11.37; 95% confidence interval, −12.89 to −9.85) compared with controls. These results suggest that stem cell therapy could improve neurological function deficits and infarct volume, exerting potential neuroprotective effect for experimental ischemic stroke, but further clinical studies are still needed.

History

References